SYNERON MEDICAL LTD - ORD SHS (ELOS)

CUSIP: M87245102

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / ORD SHS
Total 13F shares
26,737,664
Share change
+147,441
Total reported value
$275,929,666
Price per share
$10.32
Number of holders
60
Value change
+$95,660
Number of buys
18
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP M87245102?
CUSIP M87245102 identifies ELOS - SYNERON MEDICAL LTD - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNERON MEDICAL LTD - ORD SHS (ELOS) as of Q2 2014

As of 30 Jun 2014, SYNERON MEDICAL LTD - ORD SHS (ELOS) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 26,737,664 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, RIMA SENVEST MANAGEMENT, L.L.C., Visium Asset Management, LP, NORTH TIDE CAPITAL, LLC, JPMORGAN CHASE & CO, BRANDES INVESTMENT PARTNERS, LP, Broadfin Capital, LLC, ROYCE & ASSOCIATES LLC, HOURGLASS CAPITAL, LLC, and GRANAHAN INVESTMENT MANAGEMENT INC/MA. This page lists 60 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.